Heat Shock Protein Therapeutics for Stroke
热休克蛋白治疗中风
基本信息
- 批准号:8655914
- 负责人:
- 金额:$ 48.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAnti-DNA AntibodiesAnti-Inflammatory AgentsAnti-inflammatoryApoptosisApoptoticAstrocytesAttenuatedBehavioralBindingBiological MarkersBloodBrainCaspaseCellsCerebral IschemiaChimeric ProteinsClientCoupledDataFutureGene ExpressionGene Expression ProfilingGenesGenomeGenomicsGlucoseGreen Fluorescent ProteinsHeat shock proteinsHeat-Shock ResponseHumanIn VitroInfarctionInflammationInflammatoryInflammatory ResponseInjuryIschemiaLeukocytesMMP9 geneMeasuresMediatingMethodsMicrogliaMiddle Cerebral Artery OcclusionMitochondriaModelingMolecular ChaperonesMutateNeurodegenerative DisordersNeurogliaNeuronsNucleosidesOutcomeOxygenPathway interactionsPropertyProtein BiosynthesisProtein DenaturationProteinsRNARattusRecombinantsResearch PersonnelRodentRoleSignal TransductionSorting - Cell MovementSpinal CordStressStrokeTNF geneTherapeuticTransfectionTransgenesViralacute strokebrain cellcaspase-3caspase-9deprivationimprovedin vivoinhibitor/antagonistmutantnovelperipheral bloodprotein degradationprotein expressionprotein foldingresponse
项目摘要
ABSTRACT
Heat shock proteins, including Hsp70, are chaperones induced by heat shock and many stresses including
ischemia and assist protein folding during protein synthesis and re-folding after protein denaturation. Hsp70
protein expression is neuroprotective in a variety of models using a number of different methods of over
expression. This proposal will address protective, anti-apoptotic and anti-inflammatory roles of Hsp70 in: (1)
primary cultures of neurons and glia; and (2) following focal cerebral ischemia. A novel aspect of the study will
be to intravenously administer recombinant Hsp70, Hsp70C and mutant Hsp70C-DEVD proteins using a newly
developed single-chain fragment of an anti-DNA antibody referred to as Fv. Fv-Hsp70 binds to the nucleoside
salvage transporter ENT2 found on all cells and the Fv-Hsp70 enters these cells via the ATP independent ENT2
transporter. Our preliminary data show: (a) that Fv-Hsp70 protects neurons and glia in vitro; (b) FvHsp70
decreases infarct volumes and improves behavioral outcomes following middle cerebral artery occlusions
(MCAO) in vivo; (c) and pro-inflammatory and pro-apoptotic genes induced in blood leukocytes following
MCAO are decreased by treatment with FvHsp70 in vivo. Therefore, we propose the following aims.
Specific Aim #1a: Demonstrate that Fv-Hsp70, Fv-Hsp70C and mutant Fv-Hsp70C-DEVD protect cultured
neurons and astrocytes from oxygen glucose deprivation (OGD). Specific Aim #1b: Begin to explore the anti-
apoptotic and anti-inflammatory mechanisms of protection by examining the interaction between Hsp70, NF¿B
and TNF in primary cells from brain; and show that Hsp70 blocks NF¿B activation in primary brain cells.
Specific Aim #2: Demonstrate that the Fv-Hsp70 constructs decrease infarct volumes and improve behavioral
outcomes in rat models of focal cerebral ischemia. The effects of Fv-Hsp70, Fv-Hsp70C and Fv-Hsp70C-DEVD
will be compared to each other and to vehicle, Hsp70 alone, Fv alone and Fv-Green Fluorescent Protein (GFP)
controls. Specific Aim #3a. Perform genomic profiling of rat blood following the MCAO strokes produced in
Aim #2 and demonstrate that MCAO induces a damaging set of pro-apoptotic and pro-inflammatory genes while
suppressing pro-survival genes in leukocytes in blood. Specific Aim #3b: Demonstrate that treatment with Fv-
Hsp70 constructs in rats following MCAO attenuates the deleterious gene response in blood leukocytes and will
increase anti-apoptotic, increase anti-inflammatory and increase other pro-survival genes in rat blood leukocytes.
Significance: These studies will provide a proof of principle that Hsp70, administered intravenously as a Fv-
fusion protein, enters brain and improves outcome from stroke. More generally, the Fv protein delivery method
used here could be useful for delivering any protein to treat stroke, other acute injuries to the brain and spinal
cord, and possibly to treat degenerative neurological diseases. We also propose that monitoring gene expression
changes in peripheral blood that correlate with effective stroke treatments in rodents can be used to assess
potential treatment responsiveness in humans.
摘要
热休克蛋白,包括Hsp70,是由热休克和许多应激诱导的伴侣蛋白,包括
在蛋白质合成和蛋白质变性后的再折叠过程中,缺血和辅助蛋白质折叠。热休克蛋白70
在使用多种不同方法的各种模型中,蛋白质的表达具有神经保护作用
表情。这项提案将解决Hsp70在以下方面的保护、抗凋亡和抗炎作用:(1)
原代培养神经元和神经胶质细胞;(2)局灶性脑缺血后。这项研究的一个新方面将是
将重组Hsp70、Hsp70C和突变型Hsp70C-DEVD蛋白通过一种新的
开发了一种被称为Fv的抗DNA抗体的单链片段。Fv-Hsp70与核苷结合
在所有细胞上都发现了补救转运蛋白ent2,Fv-Hsp70通过不依赖于ATP的ent2进入这些细胞
传送器。我们的初步数据显示:(A)Fv-Hsp70在体外保护神经元和神经胶质细胞;(B)FvHsp70
大脑中动脉闭塞后缩小脑梗塞体积和改善行为结局
(C)在下列情况下在血白细胞中诱导的促炎基因和促凋亡基因
体内应用FvHsp70可减少大脑中动脉闭塞。因此,我们提出以下目标。
特异性目标#1a:证明Fv-Hsp70、Fv-Hsp70C和突变体Fv-Hsp70C-DEVD对培养的动物具有保护作用
缺氧缺糖(OGD)引起的神经元和星形胶质细胞。具体目标#1b:开始探索反
热休克蛋白70、核因子B相互作用对细胞凋亡和抗炎保护机制的研究
和肿瘤坏死因子;并表明HSP70阻断了原代脑细胞中的核因子B的激活。
具体目标2:证明FV-Hsp70结构可减少脑梗塞体积并改善行为学
大鼠局灶性脑缺血模型的转归。Fv-Hsp70、Fv-Hsp70C和Fv-Hsp70C-DEVD的作用
将相互比较,并与载体、单独的HSP70、单独的FV和FV-绿色荧光蛋白(GFP)进行比较
控制。具体目标#3a。在MCAO卒中后对大鼠血液进行基因组图谱分析
目的#2并证明MCAO诱导了一组破坏性的促凋亡和促炎症基因,而
抑制血液中白细胞中的促生存基因。具体目标#3b:演示使用FV-
大鼠大脑中动脉阻塞后热休克蛋白70的构建可减弱血白细胞中有害基因的反应
增强大鼠血白细胞的抗凋亡、抗炎和其他促生存基因。
意义:这些研究将提供一个原则证明,Hsp70作为Fv静脉注射-
融合蛋白,进入大脑,改善中风的预后。更广泛地说,FV蛋白递送方法
可用于输送任何蛋白质来治疗中风、脑和脊椎的其他急性损伤
脐带,可能还用于治疗退行性神经疾病。我们还建议监测基因的表达
外周血中与有效的中风治疗相关的变化可以用来评估
人类潜在的治疗反应性。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Improving the translation of animal ischemic stroke studies to humans.
- DOI:10.1007/s11011-014-9499-2
- 发表时间:2015-04
- 期刊:
- 影响因子:3.6
- 作者:Jickling, Glen C.;Sharp, Frank R.
- 通讯作者:Sharp, Frank R.
Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats.
- DOI:10.1177/0271678x15610786
- 发表时间:2016-08
- 期刊:
- 影响因子:0
- 作者:Liu da Z;Jickling GC;Ander BP;Hull H;Zhan X;Cox C;Shroff N;Dykstra-Aiello C;Stamova B;Sharp FR
- 通讯作者:Sharp FR
Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential.
- DOI:10.1007/s12975-013-0271-4
- 发表时间:2013-12
- 期刊:
- 影响因子:6.9
- 作者:Sharp, Frank R.;Zhan, Xinhua;Liu, Da-Zhi
- 通讯作者:Liu, Da-Zhi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Nishimura其他文献
Robert Nishimura的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Nishimura', 18)}}的其他基金
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation
细胞内靶向 Hsp70 用于毒素吸入后的肺细胞保护
- 批准号:
8610201 - 财政年份:2013
- 资助金额:
$ 48.84万 - 项目类别:
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation
细胞内靶向 Hsp70 用于毒素吸入后的肺细胞保护
- 批准号:
8920321 - 财政年份:2013
- 资助金额:
$ 48.84万 - 项目类别:
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation
细胞内靶向 Hsp70 用于毒素吸入后的肺细胞保护
- 批准号:
8741964 - 财政年份:2013
- 资助金额:
$ 48.84万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.84万 - 项目类别:
Research Grant














{{item.name}}会员




